PRACTICEUPDATE.COM: Keyword Density Checker

Total words: 3464 | 2-word phrases: 880 | 3-word phrases: 990 | 4-word phrases: 1064

PAGE INFO

Title	Try to keep the title under 60 characters (20 characters) center of excellence
Description	Try to keep the meta description between 50 - 160 characters (105 characters) PracticeUpdate connects healthcare professionals with the information that matters most for patient care.
Keywords	Meta keywords are not recommended anymore (105 characters) PracticeUpdate, Elsevier, journals, news, commentary, Oncology
H1	H1 tag on the page (26 characters) Welcome to PracticeUpdate,

#	Keyword	Frequency	Density
1	· june 27	9	0.91%
2	editor in chief	9	0.91%
3	june 27 2024	9	0.91%
4	md editor in	6	0.61%
5	in patients with	5	0.51%
6	interview · june	5	0.51%
7	med · june	5	0.51%
8	n engl j	5	0.51%
9	healthday · june	5	0.51%
10	featured early career	5	0.51%
11	story of the	5	0.51%
12	early career ·	4	0.40%
13	of the week	4	0.40%
14	and dexamethasone for	4	0.40%
15	dexamethasone for multiple	4	0.40%
16	for multiple myeloma	4	0.40%
17	oncol · june	4	0.40%
18	in advanced melanoma	4	0.40%
19	june 25 2024	3	0.30%
20	· june 25	3	0.30%
21	2024 back next	3	0.30%
22	upfront vs no	3	0.30%
23	relapsedrefractory multiple myeloma	3	0.30%
24	engl j med	3	0.30%
25	1 expert comment	3	0.30%
26	· june 21	3	0.30%
27	resection of the	3	0.30%
28	there are no	3	0.30%
29	2024 asco featured	3	0.30%
30	synchronous metastatic colorectal	3	0.30%

#	Keyword	Frequency	Density
1	· june 27 2024	9	0.85%
2	md editor in chief	6	0.56%
3	med · june 27	4	0.38%
4	story of the week	4	0.38%
5	and dexamethasone for multiple	4	0.38%
6	engl j med ·	3	0.28%
7	n engl j med	3	0.28%
8	interview · june 21	3	0.28%
9	dexamethasone for multiple myeloma	3	0.28%
10	upfront vs no resection	3	0.28%
11	j med · june	3	0.28%
12	no resection of the	3	0.28%
13	myeloma n engl j	3	0.28%
14	multiple myeloma n engl	3	0.28%
15	tumor in patients with	3	0.28%
16	oncol · june 27	3	0.28%
17	· june 25 2024	3	0.28%
18	healthday · june 25	3	0.28%
19	of the week belantamab	3	0.28%
20	primary tumor in patients	3	0.28%
21	2023 featured early career	3	0.28%
22	for multiple myeloma n	3	0.28%
23	vs no resection of	3	0.28%
24	early career · july	2	0.19%
25	glofitamabgemox superior to rituximabgemox	2	0.19%
26	lenalidomide and dexamethasone for	2	0.19%
27	prophylaxis beneficial in leukemia	2	0.19%
28	immunotherapies in advanced melanoma	2	0.19%
29	· june 23 2024	2	0.19%
30	update your settings with	2	0.19%
31	please update your settings	2	0.19%
32	· june 26 2024	2	0.19%
33	transplantation n engl j	2	0.19%
34	nonsignificant survival benefit seen	2	0.19%
35	breast cancer j clin	2	0.19%
36	david rakel md faafp	2	0.19%
37	june 27 2024 featured	2	0.19%
38	ann oncol · june	2	0.19%
39	with synchronous metastatic colorectal	2	0.19%
40	patients with synchronous metastatic	2	0.19%

#	URL	Whois	Check
1	https://www.microsoft.com/en-us/WindowsForBusiness/End-of-IE-support	Whois	microsoft.com
2	http://browsehappy.com/	Whois	browsehappy.com
3	https://service.elsevier.com/app/home/supporthub/practice-update/	Whois	elsevier.com
4	https://service.elsevier.com/app/contact/supporthub/practice-update/	Whois	elsevier.com
5	https://www.facebook.com/practiceupdate	Whois	facebook.com
6	https://www.twitter.com/practiceupdate	Whois	twitter.com
7	https://www.instagram.com/practiceupdate_elsevier/	Whois	instagram.com
8	https://www.linkedin.com/company/practiceupdate	Whois	linkedin.com
9	https://www.youtube.com/PracticeUpdate	Whois	youtube.com
10	https://www.facebook.com/ElsevierConnect	Whois	facebook.com
11	https://www.linkedin.com/company/elsevier	Whois	linkedin.com
12	https://twitter.com/ElsevierConnect	Whois	twitter.com
13	https://www.youtube.com/c/elsevier	Whois	youtube.com
14	https://www.clinicalkey.com/pharmacology	Whois	clinicalkey.com
15	https://www.clinicalkey.com/	Whois	clinicalkey.com
16	https://www.elsevier.com/online-tools/embase	Whois	elsevier.com
17	https://evolve.elsevier.com	Whois	elsevier.com
18	https://www.sciencedirect.com	Whois	sciencedirect.com